SARA MILLER: Open Payments
NPI 1336927441 · KAMAS, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $77 |
| ABBVIE INC. | 3 | $50 |
| Novo Nordisk Inc | 2 | $33 |
| Tris Pharma Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Corium, LLC | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Organon LLC | 1 | $14 |
Products named: ZAVZPRET, QULIPTA, Dyanavel XR, AIRSUPRA, Wegovy, Azstarys, ZORYVE, JARDIANCE.
Industry payments across UT — which companies pay providers there.
